1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow edifoligide: new trials by email Literature Review of edifoligide trials Research Report on edifoligide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis edifoligide (E2F Decoy) - Hyperplasia, Chronic Renal Failure | Phase 1 / Phase 2 | Terminated | Anesiva, Inc. | 2004-05-01 | 2005-07-19 |
Hyperplasia (1) · Kidney Failure, Chronic (1)
Anesiva, Inc. (1)
United States (1)